Mark E. Brooke‐Smith
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Liver Disease and Transplantation 4
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 6
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
- Pancreatitis Pathology and Treatment 4
- Organ Transplantation Techniques and Outcomes 4
- Gastrointestinal disorders and treatments 3
- Emergency Medicine top 10%
-
- Gallbladder and Bile Duct Disorders 2
- Co-authors
- J. ToouliC W ImriePatrick C. FreenyD L Carr-LockeJennifer J. TelfordClaudio BassiRadhika TandonJames Toouli
- Cited by
- HepatologyOncologySurgery
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark E. Brooke‐Smith
18 papers receiving 746 citations
Peers
Comparison fields: 5 of 68
- Hepatology 138
- Oncology 424
- Surgery 593
- Emergency Medicine 74
- Pulmonary and Respiratory Medicine 199
Countries citing papers authored by Mark E. Brooke‐Smith
This map shows the geographic impact of Mark E. Brooke‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Brooke‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Brooke‐Smith more than expected).
Fields of papers citing papers by Mark E. Brooke‐Smith
This network shows the impact of papers produced by Mark E. Brooke‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Brooke‐Smith. The network helps show where Mark E. Brooke‐Smith may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark E. Brooke‐Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 13 | |
| 4 | 2019 | 0 | |
| 5 | 2017 | 10 | |
| 6 | 2017 | 57 | |
| 7 | 2015 | 10 | |
| 8 | 2015 | 17 | |
| 9 | 2014 | 92 | |
| 10 | 2013 | 44 | |
| 11 | 2013 | 2 | |
| 12 | 2013 | 12 | |
| 13 | 2012 | 20 | |
| 14 | 2010 | 90 | |
| 15 | 2008 | 13 | |
| 16 | Highly selective inhibition of inducible nitric oxide synthase ameliorates experimental acute pancreatitis. | 2005 | 17 |
| 17 | 2004 | 38 | |
| 18 | 2004 | 6 | |
| 19 | 2004 | 1 | |
| 20 | 2002 | 324 |
About Mark E. Brooke‐Smith
Mark E. Brooke‐Smith is a scholar working on Hepatology, Surgery, Transplantation, Internal Medicine and Oncology, having authored 20 papers that have together received 773 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pancreatitis Pathology and Treatment (4 papers), Liver Disease and Transplantation (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Gastrointestinal disorders and treatments (3 papers) and Gallbladder and Bile Duct Disorders (2 papers). The work is most often cited by research in Hepatology (138 citations), Oncology (424 citations), Surgery (593 citations), Emergency Medicine (74 citations) and Pulmonary and Respiratory Medicine (199 citations). Mark E. Brooke‐Smith has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include J. Toouli, C W Imrie, Patrick C. Freeny, D L Carr-Locke, Jennifer J. Telford, Claudio Bassi, Radhika Tandon, James Toouli, Thomas G. Wilson and Robert T. A. Padbury. Their work appears in journals such as HPB, Cancers, Pancreas, ANZ Journal of Surgery and Clinical Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.